Severe Multifactorial Lactic Acidosis With Pulmonary Edema and Myocardial Injury in an Elderly Patient on Metformin Managed Conservatively: A Case Report
Abstract
Severe lactic acidosis is a life-threatening condition in elderly patients with multiple comorbidities. We report a 90-year-old man with type 2 diabetes mellitus (HbA1c 7.1%), hypertension, and chronic kidney disease (CKD) stage 3a (baseline estimated glomerular filtration rate (eGFR) of 56 mL/min/1.73 m²) who presented with acute dyspnea, orthopnea, and oliguria. Laboratory evaluation revealed metabolic acidaemia (pH 7.22), marked hyperlactatemia (8 mmol/L), and acute-on-chronic kidney injury. Clinical findings were consistent with acute pulmonary edema and myocardial injury, with elevated cardiac biomarkers but no ischemic electrocardiographic changes. Lactic acidosis was multifactorial, driven by sepsis from a diabetic foot infection, renal dysfunction, and metformin as a potential contributor. Initial management included intravenous sodium bicarbonate, loop diuretics, ventilatory support, and antimicrobial therapy. Renal replacement therapy was declined by the patient, and intensive conservative management with close biochemical and clinical monitoring was pursued. The patient gradually improved, with normalization of acid-base status, renal function, lactate, and cardiac biomarkers, allowing successful extubation and transition to oral therapy. This case highlights the diagnostic and therapeutic challenges of severe lactic acidosis in elderly patients with multiple comorbidities and demonstrates that individualized supportive care can lead to favorable outcomes even…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.